Effect of eight weeks of interval training on insulin signaling and neurodegeneration in the hippocampus of Methamphetamine-treated rats

A Ahad Shafiei A Amir Hossein Haghighi M Majid Asadi-Shekaari M Mahla Sadat Nabavi-Zadeh R Roya Askari H Hamid Marefati H Hadi Shahrabadi A Alfredo Caturano R Rosario Barone R Roberto Bei P Pasquale Farsetti A Attilio Parisi F Ferdinando Iellamo M Marco Alfonso Perrone

Abstract

Abstract This study investigated the effect of eight weeks of interval training on insulin signaling and neurodegeneration in the hippocampus of methamphetamine (METH)-treated rats. Thirty-two male Wistar rats were randomly divided into four equal groups ( n  = 8): saline, METH-1 (21-days of injection period), METH-2 (21-day injection period, followed by 8-week withdrawal), and METH+moderate-intensity interval training (MIT). Methamphetamine was injected intraperitoneally at 5 mg/kg per day for a period of 21 consecutive days. MIT was conducted on a treadmill at 60–65% of maximum speed, 5 days weekly for 8 weeks. At the end of the injection and training period, the hippocampal tissue of rats was extracted to evaluate the pathological changes and gene expression of related indicators. METH injection caused a disturbance in the insulin signaling pathway, resulting in increased neurodegeneration, as evidenced by a decrease in the expression of IRS-1 ( p  < 0.001) and Akt ( p  < 0.001) genes as well as an increase in the expression of GSK-3β ( p  < 0.001), APP ( p  = 0.007), tau ( p  = 0.006), p-tau ( p  < 0.001), and Caspases-3 ( p  = 0.003) genes. However, MIT significantly upregulated the expression of IRS-1 ( p  < 0.001) and Akt ( p  = 0.002), while downregulating APP ( p  = 0.028) and p-tau ( p  < 0.001). These findings suggest that MIT enhances insulin signaling activity and improves anxiety-like behaviors, thereby counteracting the detrimental effects of METH. Further studies are required to expand and validate these findings.

Article Details

Volume / Issue Vol. 16, Issue 1
Published February 27, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (14)

A

Ahad Shafiei

A

Amir Hossein Haghighi

M

Majid Asadi-Shekaari

M

Mahla Sadat Nabavi-Zadeh

R

Roya Askari

H

Hamid Marefati

H

Hadi Shahrabadi

A

Alfredo Caturano

R

Rosario Barone

R

Roberto Bei

P

Pasquale Farsetti

A

Attilio Parisi

F

Ferdinando Iellamo

M

Marco Alfonso Perrone